Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,365,849
-
Share change
-
+198,170
-
Total reported value
-
$7,639,000
-
Put/Call ratio
-
0%
-
Price per share
-
$1.20
-
Number of holders
-
27
-
Value change
-
+$213,719
-
Number of buys
-
12
-
Number of sells
-
11
Institutional Holders of REPROS THERAPEUTICS INC - COM NEW (RPRX) as of Q1 2017
As of 31 Mar 2017,
REPROS THERAPEUTICS INC - COM NEW (RPRX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,365,849 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GENERAL AMERICAN INVESTORS CO INC, Allegis Investment Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.